NasdaqGS - Delayed Quote • USD
Poseida Therapeutics, Inc. (PSTX)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 6:33 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 33.31M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| RIZVI SYED ALI-AAMIR M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| LEONHARDT HARRY J. ESQ. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| MYLET JOHANNA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| WARNER BRENT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| GERGEN MARK J Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| YAREMA KRISTIN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| LLOYD MARCEA BLAND Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 15, 2023 |
| COLLINS CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 15, 2023 |
| SCHMID JOHN P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 15, 2023 |
| BAUM CHARLES M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 15, 2023 |
| CORNING LUKE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 15, 2023 |
| AMADO RAFAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 1, 2023 |
| YAREMA KRISTIN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 11, 2023 |
| LEONHARDT HARRY J. ESQ. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| GERGEN MARK J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| MYLET JOHANNA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| WARNER BRENT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.50 per share. | Direct | 7,525,000 | Aug 8, 2022 |
| OSTERTAG ERIC Officer, Director and Beneficial Owner | Purchase at price 3.50 per share. | Direct | 500,000 | Aug 8, 2022 |
| OSTERTAG ERIC Officer, Director and Beneficial Owner | Sale at price 3.69 per share. | Indirect | 592,808 | Aug 3, 2022 |
| LLOYD MARCEA BLAND Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 16, 2022 |
| COLLINS CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 16, 2022 |
| SCHMID JOHN P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 16, 2022 |
| BAUM CHARLES M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 16, 2022 |
| CORNING LUKE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 16, 2022 |
| INGALLS KERRY D Chief Operating Officer | Purchase at price 3.98 per share. | Direct | 11,940 | Mar 16, 2022 |
| LEONHARDT HARRY J. ESQ. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2022 |
| INGALLS KERRY D Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2022 |
| MYLET JOHANNA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2022 |
| SPEAR MATTHEW A. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2022 |
| WARNER BRENT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2022 |
| GERGEN MARK J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2022 |
| OSTERTAG ERIC Officer, Director and Beneficial Owner | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2022 |
| OSTERTAG ERIC Officer, Director and Beneficial Owner | Stock Gift at price 0.00 per share. | Indirect | 0 | Dec 30, 2021 |
| MYLET JOHANNA Chief Financial Officer | Conversion of Exercise of derivative security at price 1.17 - 1.93 per share. | Direct | 9,061 | Dec 21, 2021 |
| MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.90 per share. | Direct | 12,613 | Dec 6, 2021 |
| SPEAR MATTHEW A. Officer | Conversion of Exercise of derivative security at price 1.32 per share. | Direct | 13,220 | Dec 6, 2021 |
| MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.85 - 6.88 per share. | Direct | 351,194 | Dec 2, 2021 |
| MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.81 - 6.89 per share. | Direct | 268,962 | Nov 29, 2021 |
| MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.77 - 7.44 per share. | Direct | 181,640 | Nov 23, 2021 |
| OSTERTAG ERIC Chief Executive Officer | Conversion of Exercise of derivative security at price 9.15 per share. | Direct | 9,150 | Nov 19, 2021 |
| MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.17 - 7.21 per share. | Direct | 2,731,889 | Nov 18, 2021 |
| INGALLS KERRY D Chief Operating Officer | Purchase at price 7.00 per share. | Direct | 14,000 | Nov 17, 2021 |
| OSTERTAG ERIC Chief Executive Officer | Sale at price 7.09 per share. | Indirect | 134,171 | Nov 8, 2021 |
| OSTERTAG ERIC Chief Executive Officer | Conversion of Exercise of derivative security at price 9.15 per share. | Direct | 169,504 | Oct 11, 2021 |
| OSTERTAG ERIC Chief Executive Officer | Sale at price 7.02 per share. | Indirect | 140,604 | Oct 1, 2021 |
| OSTERTAG ERIC Chief Executive Officer | Sale at price 8.00 per share. | Indirect | 160,020 | Sep 20, 2021 |
| OSTERTAG ERIC Chief Executive Officer | Sale at price 8.14 per share. | Indirect | 162,712 | Sep 14, 2021 |
| OSTERTAG ERIC Chief Executive Officer | Conversion of Exercise of derivative security at price 1.17 - 9.15 per share. | Direct | 172,729 | Sep 13, 2021 |
| SPEAR MATTHEW A. Officer | Conversion of Exercise of derivative security at price 1.32 per share. | Direct | 13,220 | Sep 9, 2021 |
Related Tickers
ALLO Allogene Therapeutics, Inc.
3.0400
-9.79%
PASG Passage Bio, Inc.
1.2400
+0.81%
PMVP PMV Pharmaceuticals, Inc.
1.6900
-6.37%
ADAP Adaptimmune Therapeutics plc
1.0800
-5.26%
INAB IN8bio, Inc.
1.0600
+1.92%
ORIC ORIC Pharmaceuticals, Inc.
8.08
-7.87%
OABI OmniAb, Inc.
4.5600
-1.72%
EVGN Evogene Ltd.
0.6695
+1.49%
BCAB BioAtla, Inc.
2.3500
+4.91%
NKTX Nkarta, Inc.
7.17
-5.16%